Zylox-Tonbridge Medical Technology Co (HKSE:02190) Cash-to-Debt : 27.04 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Zylox-Tonbridge Medical Technology Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 27.04.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Zylox-Tonbridge Medical Technology Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Zylox-Tonbridge Medical Technology Co's Cash-to-Debt or its related term are showing as below:

HKSE:02190' s Cash-to-Debt Range Over the Past 10 Years
Min: 4.2 Med: 27.04 Max: 311.42
Current: 27.04

During the past 5 years, Zylox-Tonbridge Medical Technology Co's highest Cash to Debt Ratio was 311.42. The lowest was 4.20. And the median was 27.04.

HKSE:02190's Cash-to-Debt is ranked better than
81.45% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: 1.9 vs HKSE:02190: 27.04

Zylox-Tonbridge Medical Technology Co Cash-to-Debt Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Cash-to-Debt Chart

Zylox-Tonbridge Medical Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

4.20

9.27

311.42

132.88

27.04

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial				311.42	248.19	132.88	85.78	27.04

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's Cash-to-Debt

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zylox-Tonbridge Medical Technology Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Cash-to-Debt falls into.

Zylox-Tonbridge Medical Technology Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Zylox-Tonbridge Medical Technology Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1652.557	/	(59.084	+	2.033)
	=	27.04

Zylox-Tonbridge Medical Technology Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1652.557	/	(59.084	+	2.033)
	=	27.04

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Zylox-Tonbridge Medical Technology Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Keji Avenue, Yuhang Street, 1st & 2nd Floors, Building 1, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries.

Executives

Gan Zhou Ti Tan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2501 Other
Su Zhou Tai Hong Jing Hui Tou Zi Zhong Xin You Xian He Huo	2501 Other
Five Investment Limited	2501 Other
Highlight Medical Limited	2501 Other
Ourea Biotech Hk Limited	2501 Other
Wang Stephen Hui	2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Tie Si Yi Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2501 Other
Jia Jian Tou Zi You Xian Gong Si	2501 Other
Wea Enterprises ,llc	2401 A concert party to an agreement to buy shares
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Ning Bo Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Li Zheng	2501 Other

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Headlines

No Headlines